Based on the tau binding data obtained with AD brain-derived homogenates and PK data, compounds 4 and 7 were selected for a PK study in NHP rhesus macaque (Macaca mulatta) performed at Molecular Neuroimaging LLC (MNI), New Haven, CT, USA. The gene discussed is MAPT; the disease is Alzheimer disease.